MENU
TRDA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Entrada Therapeutics (TRDA) Earnings Date & Reports

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more

A.I. Advisor
published Earnings

TRDA is expected to report earnings to -100 cents per share on November 10

Entrada Therapeutics TRDA Stock Earnings Reports
Q3'26
Est.
$-1.01
Q2'26
Beat
by $0.04
Q1'26
Beat
by $0.07
Q4'25
Beat
by $0.04
Q3'25
Missed
by $0.07
The last earnings report on August 05 showed earnings per share of -100 cents, beating the estimate of -104 cents. With 39.81K shares outstanding, the current market capitalization sits at 242.19M.